Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01233388 · ClinicalTrials.gov registry record
Real-time Influenza Vaccine Surveillance
A clinical trial of Vaccine Safety, sponsored by Columbia University.
- Completed
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT01233388: Completed study of Vaccine Safety, sponsored by Columbia University.
NCT01233388 is a study of Vaccine Safety that has completed, run by Columbia University. The registered enrollment target is 400 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01233388, a study of Vaccine Safety, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this proposal is to pioneer the implementation and evaluation of a novel patient centered text messaging vaccine adverse event surveillance network.
Primary Outcome
As this is a pilot study, we want to first determine if people will report health problems. Therefore, we will assess the number of participants who report a health problem within 6 weeks of vaccination.
Conditions Studied
Interventions
- OTHER Text message surveillance
Study Locations (1)
New York
- Columbia University Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2010-11 |
| Est. Completion | 2012-05 |
What the finished NCT01233388 record still lists
NCT01233388 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Vaccine Safety appearing as the primary indexed condition, and to 1 intervention - of which Text message surveillance is the first listed.
NCT01233388 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01233388 about?
NCT01233388 is a clinical study titled "Real-time Influenza Vaccine Surveillance". The aim of this proposal is to pioneer the implementation and evaluation of a novel patient centered text messaging vaccine adverse event surveillance network.
What is the current status of trial NCT01233388?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2010-11. Estimated completion is 2012-05.
What conditions does trial NCT01233388 study?
This clinical trial studies the following conditions: Vaccine Safety.
What interventions are being tested in trial NCT01233388?
The interventions under investigation include: Text message surveillance (OTHER).
Who is sponsoring clinical trial NCT01233388?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01233388 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia